Codacci-Pisanelli G, Noordhuis P, van der Wilt C L, Peters G J
Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):733-9. doi: 10.1080/15257770802145496.
Fluorouracil (5FU) acts by RNA-incorporation and inhibition of thymidylate synthase; the first action is counteracted by uridine, and the second is enhanced by leucovorin (LV). Growth inhibition of C26-10 colon cancer cells by 5FU was enhanced by LV and rescued by uridine, but 5FU-LV was only partially rescued by uridine. In WiDr cells, 5FU sensitivity was not enhanced by LV, while both 5FU and 5FU-LV were rescued by uridine. Intermediate trends were found in SW948 and HT29 cells. Uridine rescue in mice allowed 1.5-fold increase in 5FU dose, leading to 2-fold increase in the antitumor effect and thymidylate synthase inhibition in resistant Colon-26 tumors. In the sensitive Colon-26-10 tumor, uridine rescue decreased 5FU-RNA incorporation > 10-fold, without affecting the antitumor activity. The use of LV and uridine can differentiate between two mechanisms of action of 5FU.
氟尿嘧啶(5FU)通过掺入RNA和抑制胸苷酸合成酶发挥作用;第一个作用可被尿苷抵消,第二个作用可被亚叶酸(LV)增强。LV增强了5FU对C26-10结肠癌细胞的生长抑制作用,尿苷可逆转该作用,但5FU-LV仅被尿苷部分逆转。在WiDr细胞中,LV未增强5FU的敏感性,而尿苷可逆转5FU和5FU-LV的作用。在SW948和HT29细胞中发现了中间趋势。在小鼠中,尿苷解救可使5FU剂量增加1.5倍,导致耐药性结肠26肿瘤的抗肿瘤作用和胸苷酸合成酶抑制作用增加2倍。在敏感的结肠26-10肿瘤中,尿苷解救使5FU-RNA掺入减少>10倍,而不影响抗肿瘤活性。使用LV和尿苷可以区分5FU的两种作用机制。